+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Paclitaxel"

Ovarian Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Ovarian Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Paclitaxel Injection Global Market Report 2024 - Product Thumbnail Image

Paclitaxel Injection Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • May 2024
  • 184 Pages
  • Global
From
From
Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
Advanced ovarian cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced ovarian cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 210 Pages
  • Global
From
Brain Metastasis from Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Metastasis from Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
From
From
From
From
From
Abraxane - Product Thumbnail Image

Abraxane

  • Report
  • August 2018
  • 48 Pages
  • Global
From
Loading Indicator

Paclitaxel is a chemotherapy drug used to treat breast cancer. It is a semi-synthetic derivative of the natural product Taxol, which is extracted from the bark of the Pacific yew tree. Paclitaxel works by interfering with the normal process of cell division, preventing cancer cells from dividing and growing. It is typically used in combination with other drugs, such as doxorubicin, to treat advanced stages of breast cancer. Paclitaxel is available in both intravenous and oral formulations, and is often used in combination with other drugs to treat metastatic breast cancer. It is also used to treat other types of cancer, such as ovarian and lung cancer. Paclitaxel is marketed by several pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, and Sanofi. It is also available as a generic drug in some countries. Companies in the Paclitaxel market include Bristol-Myers Squibb, Pfizer, Sanofi, Mylan, Teva Pharmaceuticals, and Apotex. Show Less Read more